Back to BPMCView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
2 competitors in Indolent Systemic Mastocytosis
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
regorafenibPhase 3
GIST
avapritinibPhase 3
Solid Tumor, Unspecified, Child
CS3007 (BLU-285)Phase 2
Gastrointestinal Stromal Tumors
Phase Ib: Fisogatinib (BLU-554) in combination with Sugemalimab (CS1001)Phase 2
Hepatocellular Carcinoma
Phase II: Fisogatinib (BLU-554) in combination with Sugemalimab (CS1001)Phase 2
Hepatocellular Carcinoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts